Two Sigma Investments Adds $34M in Amprius Technologies, Inc. ($AMPX)

Key Points

  • Two Sigma Investments changed its Amprius Technologies, Inc. ($AMPX) stake by 144.0% last quarter, boosting to 3,506,075 shares worth $57.18 million.
  • Wall Street's consensus rating on $AMPX is Strong Buy and an average price target of $22.12.
  • $AMPX last traded around $16.31.

Two Sigma Investments increased its position in Amprius Technologies, Inc. ($AMPX) by 144.0% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,506,075 shares of Amprius Technologies, Inc. after buying 2,069,136 shares during the quarter. Two Sigma Investments's holdings in Amprius Technologies, Inc. were worth $57.18 million as of its most recent filing.

Amprius Technologies, Inc. ($AMPX) Stock

Last price$16.31
Market cap$2.31B
Forward P/E281.21
Beta2.13
52-week low$3.43
52-week high$24.23
50-day MA$18.73
200-day MA$13.49
Current ratio7.13
Quick ratio6.11
Debt-to-equity0.06

Amprius Technologies, Inc. Earnings

EPS (ttm)$-0.31
Revenue (ttm)$90.26M
Revenue growth152.9%
Net margin-44.0%
Return on equity-44.2%
Next earningsAug 6, 2026

Analysts Set New Price Targets

ConsensusStrong Buy
Average target$22.12
High target$25.00
Low target$18.00
Analysts covering8

About Amprius Technologies, Inc.

Amprius Technologies, Inc. develops, manufactures, and markets lithium-ion batteries for mobility applications. The company provides silicon anode lithium-ion batteries under the SiCore and SiMaxx product platforms. Its batteries are primarily used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites. The company was founded in 2008 and is headquartered in Fremont, California.

ExchangeNYSE
SectorIndustrials
IndustryElectrical Equipment & Parts
HeadquartersFremont, CA
CEOMr. Thomas Michael Stepien
Employees97

See Also

This instant news alert was generated by automated narrative technology and financial data from Trueearnings and public regulatory filings. It is for informational purposes only and is not financial advice.